This content is machine translated Newly diagnosed multiple myeloma Does a proteasome inhibitor offer new therapeutic options? One study discussed at the ASH meeting involved a regimen consisting of oral MLN9708 administered twice weekly plus lenalidomide and dexamethasone in patients with newly diagnosed multiple myeloma. It concludes…
View Post 2 min This content is machine translated Multiple Myeloma Media Workshop Which form of therapy is suitable for whom? At a media workshop during the ASH Congress in New Orleans, some key points of myeloma research were presented. They also discussed what these innovations mean for patients and used…
View Post 2 min This content is machine translated Lymphomas Integrative lymphoma diagnostics plays a central role For lymphoma diagnosis, a multimodality additive approach, which consists of history taking, clinical examination, laboratory parameters, histopathological findings, genetic findings, and static or functional (e.g., PET-CT, spectroscopy) imaging, is essential.
View Post 6 min This content is machine translated Nodal lymphoma from the pathology point of view Update for daily practice A persistent lymphadenopathy is a clear indication for further histopathological diagnosis. A detailed medical history as well as knowledge of previous diseases, manipulations and drug therapies are essential for a…
View Post 4 min This content is machine translated Primary CNS lymphoma Advanced MRI diagnostics (spectroscopy, DWI, PWI) and MRI-guided biopsy. Introduction: Primary CNS lymphomas, predominantly of the B-cell type, are rare tumors with a peak incidence in middle to older age. Conventional MRI examination yields essentially nonspecific findings of a…
View Post 4 min This content is machine translated Multiple Myeloma and MDS Something has happened in therapy The diagnosis and treatment of multiple myeloma (MM) and myelodysplastic syndromes (MDS) have undergone great development in recent years. Modern diagnostic procedures became qualitatively better and more widely available, new…
View Post 2 min This content is machine translated On our own account We stand for topicality Dear readers
View Post 5 min This content is machine translated Non-Hodgkin's Lymphoma “The new drugs will fundamentally change the therapeutic landscape” In an interview with InFo ONCOLOGY & HEMATOLOGY, Prof. Christoph Driessen, MD, Head Physician of the Department of Oncology/Hematology at the Cantonal Hospital St. Gallen, provides information on the pathogenesis,…
View Post 4 min This content is machine translated Hematology New possibilities thanks to targeted therapy At the DGHO congress in Vienna, the focus was on new targeted therapies designed to improve the quality of life of patients with malignant hematologic diseases. In particular, medical advances…
View Post 6 min This content is machine translated Sport and fatigue in cancer Sports therapy as a component of inpatient oncological rehabilitation More than 10 years ago, studies were already able to demonstrate the positive effect of endurance and strength training on fatigue symptoms in cancer patients. Since then, there have been…
View Post 4 min This content is machine translated Cardiac markers When helpful, when misleading? The established cardiac markers BNP, NT-pro-BNP, troponins, and D-dimers are important diagnostic tools. However, they can be false-positive and thus lead to misdiagnosis. In a seminar at this year’s KHM…
